Coral Laboratories Limited (BOM:524506)
603.35
+28.70 (4.99%)
At close: Aug 17, 2026
Coral Laboratories Market Cap
Coral Laboratories has a market cap or net worth of 2.16 billion as of August 17, 2026. Its market cap has increased by 22.92% in one year.
Market Cap
2.16B
Enterprise Value
1.18B
Revenue
968.04M
Ranking
n/a
PE Ratio
11.23
Stock Price
603.35
ChartMarket Cap Chart
Since August 4, 1998, Coral Laboratories's market cap has increased from 39.30M to 2.16B, an increase of 5,385.00%. That is a compound annual growth rate of 15.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 2.16B | 37.59% |
| Dec 31, 2025 | 1.57B | -42.52% |
| Dec 31, 2024 | 2.73B | 75.31% |
| Dec 29, 2023 | 1.55B | 35.01% |
| Dec 30, 2022 | 1.15B | 3.55% |
| Dec 31, 2021 | 1.11B | 0.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Astonea Labs | 2.92B |
| Everest Organics | 2.81B |
| Gennex Laboratories | 2.63B |
| Oxygenta Pharmaceutical | 2.42B |
| Sanjivani Paranteral | 2.40B |
| Accretion Pharmaceuticals | 2.12B |
| Kerala Ayurveda | 2.04B |
| Sat Kartar Life | 1.91B |